Our long-term therapy is based on a pancreatic proenzyme formulation that suppresses tumor recurrence and metastasis.
PRP, our lead candidate, controls cancer cell migration, inhibits tumor blood vessel formation and triggers the cell’s death.
Propanc Discovers PRP Dramatically Suppresses Cancer Stem Cells
80% of all cancers are solid tumors. We are initially targeting colorectal and pancreatic tumors.
May 11, 2016
Stay informed about our latest news and updates